Pregazzi R, Levi D'Ancona R, Ricci G, Lui A, Maso G, Parco S, Piunti R
Istituto Scientifico Burlo Garofolo, Clinica Ginecologica e Ostetrica, Università degli Studi di Trieste.
Minerva Ginecol. 1994 Mar;46(3):95-8.
Experience with the collection of autologous blood during the last part of pregnancy in 57 women is reported. The authors confirm the safety of the autologous transfusion program but come to the conclusion that, with current entrance criteria, the cost-benefit ratio seems unfavourable. Therefore they suggest: a) the sole involvement of women with real potential hemorrhagic complications (placenta previa, multiple pregnancy); b) the collection, when possible, of at least 2 units of autologous blood.
报告了57名妇女在妊娠后期采集自体血的经验。作者证实了自体输血计划的安全性，但得出结论，按照目前的入选标准，成本效益比似乎不利。因此，他们建议：a）仅纳入有真正潜在出血并发症（前置胎盘、多胎妊娠）的妇女；b）尽可能采集至少2单位的自体血。
